secwatch / observer
8-K filed April 15, 2026, 7:59 PM ET ticker KVAC CIK 0001889983
M&A confidence high sentiment neutral materiality 0.30

Keen Vision Acquisition enters LOI with Medera, extends merger deadline to April 30, 2026

Keen Vision Acquisition Corp.

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0001213900-26-043759
form_type
8-K
ticker
KVAC
cik
0001889983
company_name
Keen Vision Acquisition Corp.
filed_at
2026-04-15T23:59:59+00:00
discovered_at
2026-05-14T18:02:33.242399+00:00
generated_at
2026-05-15T06:10:46.794515+00:00
sec_items
["1.01"]
event_type
m_and_a
sentiment
neutral
materiality_score
0.3
calibrated_materiality_score
0.3
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0001213900-26-043759
json_url
https://secwatch.observer/filing/0001213900-26-043759.json
markdown_url
https://secwatch.observer/filing/0001213900-26-043759.md
text_url
https://secwatch.observer/filing/0001213900-26-043759.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/1889983/000121390026043759/0001213900-26-043759-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/1889983/000121390026043759/ea0286312-8k_keen.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

479e394464772ed3ed12668d6c5dca489ba75603

Keen Vision Acquisition Corp. entered into LOI with Medera Inc. and Novoheart Group Limited.

entered into a binding letter of intent (the “LOI”) with Medera Inc., a Cayman Islands exempted company (the “Company”), and Novoheart Group Limited

SEC 8-K Item 1.01/1.02 confidence 0.7 SEC evidence

d8f2645b87f648b69bac4c85824655f2aa21a6ea

Keen Vision Acquisition Corp. amended amendment to the LOI with Medera Inc. and Novoheart Group Limited (effective 2026-04-14).

he parties entered into an amendment to the LOI dated April 14, 2026, pursuant to which the parties agreed to extend the deadline for

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

fe7ef96f975e24407b657d6aa992e614e069e144

Keen Vision Acquisition Corp. terminated prior Merger Agreement dated September 3, 2024 with Medera Inc. and Novoheart Group Limited.

prior Merger Agreement dated September 3, 2024, which was terminated concurrently with execution of the LOI pursuant to a mutual release agreement

SEC 8-K Item 1.01/1.02 confidence 0.9 SEC evidence

Comparable filings

LOKV

Live Oak enters forward purchase agreement to reduce redemptions for Teamshares merger

Live Oak Acquisition Corp. V June 2, 2026, 9:09 AM ET m_and_a Items 1.01, 9.01

same fact type: material_agreement same SEC item: 1.01 same event type: m_and_a

This filing

entered into a binding letter of intent (the “LOI”) with Medera Inc., a Cayman Islands exempted company (the “Company”), and Novoheart Group Limited

Comparable filing

On June 1, 2026, Live Oak Acquisition Corp. V, a Cayman Island exempted company (“ Live Oak ”), and a fund sub-advised by JBA Asset Management LLC (“ Seller ” or “ FPA Investor ”) entered into an agreement (the “ Forward Purchase Agreement ”) for an OTC Prepaid Share Forward Transaction-Optional Early Termination

Filing page SEC filing

WLY

Wiley acquires Emerald Publishing for $452M; adds ~500 journals, expected accretive in year one

JOHN WILEY & SONS, INC. June 2, 2026, 8:30 AM ET m_and_a Items 1.01, 2.01, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01 same event type: m_and_a

This filing

entered into a binding letter of intent (the “LOI”) with Medera Inc., a Cayman Islands exempted company (the “Company”), and Novoheart Group Limited

Comparable filing

entered into an Equity Purchase Agreement (the "Purchase Agreement") with CIG Emerald Midco LLC, a Delaware limited liability company (the "Seller"), and CIG Emerald Holding LLC, a Delaware limited liability company ("Emerald Holding"), pursuant to which Buyer acquired from the Seller all of the issued and outstanding equity securities of Emerald Holding (the "Transaction") in exchange for GBP £337.5 million (approximately $452 million)

Filing page SEC filing

TVTX

Travere licenses Everest's BTK inhibitor with $112.5M upfront, up to $1.03B milestones

Travere Therapeutics, Inc. June 2, 2026, 7:05 AM ET m_and_a Items 1.01, 9.01

same fact type: material_agreement same SEC item: 1.01 same event type: m_and_a

This filing

entered into a binding letter of intent (the “LOI”) with Medera Inc., a Cayman Islands exempted company (the “Company”), and Novoheart Group Limited

Comparable filing

On June 1, 2026, Travere Therapeutics, Inc. (the “Company”) entered into a license and collaboration agreement (the “Agreement”) with Everest Medicines (Singapore) Pte. Ltd. (“Everest”), pursuant to which Everest grants an exclusive license to the Company for the development and commercialization of civorebrutinib

Filing page SEC filing

ARXS

Arxis agrees to acquire Omnetics in ~$770M all-stock deal; closes MagCanica acquisition

Arxis, Inc. June 2, 2026, 7:00 AM ET m_and_a Items 1.01, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01 same event type: m_and_a

This filing

entered into a binding letter of intent (the “LOI”) with Medera Inc., a Cayman Islands exempted company (the “Company”), and Novoheart Group Limited

Comparable filing

On May 29, 2026, Arxis, Inc., a Delaware corporation (the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Orion Merger Sub, Inc., a Minnesota corporation and a wholly owned subsidiary of Arxis (the “Merger Sub”), Omnetics Connector Corporation, a Minnesota corporation (“Omnetics”), and Gary Jacobs, President of Omnetics, in his capacity as shareholder representative (the “Shareholder Representative”).

Filing page SEC filing

HIMS

Hims & Hers completes acquisition of Eucalyptus; reaffirms 2030 targets of $6.5B revenue

Hims & Hers Health, Inc. June 2, 2026, 6:02 AM ET m_and_a Items 1.01, 2.03, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01 same event type: m_and_a

This filing

entered into a binding letter of intent (the “LOI”) with Medera Inc., a Cayman Islands exempted company (the “Company”), and Novoheart Group Limited

Comparable filing

On May 29, 2026, Hims & Hers Health, Inc. (the “ Company ”), as borrower, entered into Amendment No. 3 (the “ Amendment ”) to the Revolving Credit and Guaranty Agreement, dated as of February 18, 2025 (as amended by that certain Amendment No. 1 to the Revolving Credit and Guaranty Agreement, dated as of June 25, 2025, that certain Amendment No. 2 to the Revolving Credit and Guaranty Agreement, dated as of May 7, 2026, and as amended by this Amendment, the “ Credit Agreement ”), by among the Company, the subsidiary borrowers and the guarantors from time to time party thereto, the lenders and issuing banks party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent.

Filing page SEC filing

HNRG

Hallador Energy acquires 460 MW Siemens turbines for $350M to advance Merom gas project

HALLADOR ENERGY CO June 2, 2026, 6:00 AM ET m_and_a Items 1.01, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01 same event type: m_and_a

This filing

entered into a binding letter of intent (the “LOI”) with Medera Inc., a Cayman Islands exempted company (the “Company”), and Novoheart Group Limited

Comparable filing

On May 30, 2026, Hallador Energy Company (the “Company”) entered into an Asset Purchase Agreement (the “APA”) with Energy World Corporation Ltd., incorporated in Australia (“Seller”), to acquire approximately 460 MW of Siemens gas turbines, generators, a steam turbine, and ancillary equipment (the “Equipment”) for an aggregate purchase price of $350 million.

Filing page SEC filing

NCSM

Weatherford to acquire NCS Multistage for 0.463 shares per NCS share; expected close H2 2026

NCS Multistage Holdings, Inc. June 1, 2026, 8:43 PM ET m_and_a Items 1.01, 5.07, 8.01, 9.01

same fact type: material_agreement same SEC item: 1.01 same event type: m_and_a

This filing

entered into a binding letter of intent (the “LOI”) with Medera Inc., a Cayman Islands exempted company (the “Company”), and Novoheart Group Limited

Comparable filing

On May 31, 2026, NCS Multistage Holdings, Inc., a Delaware corporation (“ NCS ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), by and among NCS, Weatherford International plc, an Irish public limited company (“ Weatherford ”), and Trinity Bell Sub, Inc., a Delaware corporation and wholly owned subsidiary of Weatherford (“ Merger Sub ”), pursuant to which, upon the terms and subject to the conditions set forth therein, Merger Sub will merge with and into NCS (the “ Merger ”), with NCS surviving the Merger as a wholly owned subsidiary of Weatherford.

Filing page SEC filing

Enviri II Corp

New Enviri completes spin-off; starts trading June 2 under NVRI; ~$1.2B revenue, ~$140M EBITDA

Enviri II Corp June 1, 2026, 5:18 PM ET m_and_a Items 1.01, 2.03, 3.03, 5.03, 5.01, 5.02, 5.05, 7.01, 9.01

same fact type: material_agreement same SEC item: 1.01 same event type: m_and_a

This filing

entered into a binding letter of intent (the “LOI”) with Medera Inc., a Cayman Islands exempted company (the “Company”), and Novoheart Group Limited

Comparable filing

On June 1, 2026, New Enviri entered into a transition services agreement (the “Transition Services Agreement”) with CLEH pursuant to which New Enviri will provide certain services to CLEH on an interim, transitional basis.

Filing page SEC filing

Source: SEC EDGAR
accession 0001213900-26-043759

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.